Nature's Sunshine Products, Inc. (NATR) 株式分析

企業概要

Nature's Sunshine Products, Inc. is a natural health and wellness enterprise engaged in the manufacturing and distribution of nutritional and personal care products across Asia, Europe, North America, Latin America, and international markets, with a specific focus on health solutions related to blood sugar support, bone health, and cellular function. The company operates within the Consumer Defensive sector and the Packaged Foods industry, classifications that suggest its products are essential for daily consumption and tend to exhibit resilience against economic downturns compared to discretionary spending sectors. Nature's Sunshine Products, Inc. holds a market capitalization of $473.58 million, generates annual revenue of $480.14 million, and employs 806 individuals to execute its global operational strategy. These financial figures indicate a mid-sized enterprise that maintains a significant physical presence and revenue generation capability without reaching the scale of large-cap conglomerates, positioning it as a specialized player in the global wellness market.

財務健全性

The company reported a trailing twelve-month revenue of $480.14 million and a corresponding net income of $19.52 million, while its EBITDA stood at $38.59 million, revealing a substantial gap between top-line sales and bottom-line profit that highlights the significant impact of operating expenses, cost of goods sold, and potentially interest or tax burdens on the final earnings. The firm generated free cash flow of $32.98 million, a metric that demonstrates strong operational efficiency and provides the management with financial flexibility to fund capital expenditures, repay debt, or pursue strategic acquisitions without relying on external financing. Analyzing the profitability structure, the company maintains a gross margin of 72.4%, indicating high pricing power or low direct material costs relative to sales, whereas an operating margin of 4.3% and a profit margin of 4.1% suggest that overhead costs and other operating expenses consume a considerable portion of the gross profit before reaching the net income stage. On the balance sheet, the company holds cash of $93.89 million against a total debt obligation of $18.90 million, resulting in a debt-to-equity ratio of 11.70, which presents a complex picture where high absolute cash reserves contrast with a ratio that may appear leveraged depending on the equity base, yet the net cash position suggests a conservative approach to debt servicing. Liquidity is further supported by a current ratio of 2.28, signifying that the company possesses more than double the current assets required to cover its short-term liabilities, ensuring robust short-term solvency. Additionally, the return on equity is 12.7% and the return on assets is 6.2%, metrics that reveal management's effectiveness in generating profits from shareholder capital and utilizing the company's asset base, respectively.

バリュエーション評価

The valuation of Nature's Sunshine Products, Inc. is characterized by a P/E ratio (TTM) of 25.52 and a forward P/E of 21.90, where the difference between these figures implies that the market expects earnings growth to accelerate in the future, driving the forward multiple lower than the historical trailing multiple. The price-to-book ratio stands at 2.93, indicating that the market values the company at nearly three times its net asset value, which suggests a premium pricing over the underlying book value of the firm's equity. Alternative valuation metrics provide further context, with a price-to-sales ratio of 0.99 and an EV/EBITDA of 10.33, suggesting that the stock is trading at less than one dollar of market value for every dollar of sales and offers a relatively reasonable multiple relative to its earnings before interest, taxes, depreciation, and amortization. In terms of price range, the 52-week high is $28.14 and the 52-week low is $11.15, meaning the current trading price sits at a specific point within this historical volatility range, reflecting recent market sentiment fluctuations. The stock exhibits a beta of 0.92, which indicates that the share price volatility is slightly lower than the broader market average, suggesting a slightly less reactive movement relative to general market indices.

Growth & Income

Nature's Sunshine Products, Inc. reported a year-over-year revenue growth of 4.7%, while the earnings growth rate is listed as N/A, preventing a direct comparison of earnings expansion speed against sales expansion but highlighting that top-line growth is the primary driver of recent activity. As the company does not pay a dividend, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, it follows a capital allocation strategy where earnings are retained and reinvested into the business for organic growth or expansion rather than being distributed to shareholders. This reinvestment approach is typical for companies in the growth phase that prioritize funding operations over providing immediate income returns to investors. Overall, the company presents a growth-oriented profile with moderate revenue expansion and a zero-dividend policy, relying on capital appreciation as the primary vehicle for shareholder value creation rather than income generation.